Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Resources
  • Videos Gallery
  • LRRK2 in Parkinson's disease
Video Asset Illuminator

LRRK2 in Parkinson's disease

This video describes how LRRK2 mutations and subsequent phosphorylation are key targets in Parkinson's disease.
Share:
Share via Email Share on Facebook Share on LinkedIn Share on X
Related videos
Optimizing biotherapeutic cell lines for continuous manufacturing
Biologics
Biologics
Drug Development
Drug Development

Optimizing biotherapeutic cell lines for continuous manufacturing
How to bring a gene therapy to clinical trials: A case study of a platelet-targeted gene therapy for severe Hemophilia A
Cell and Gene Therapy
Cell and Gene Therapy
Drug Development
Drug Development

How to bring a gene therapy to clinical trials: A case study of a platelet-targeted gene therapy for severe Hemophilia A
Omni Bead Ruptor Elite homogenizer specifications video
Drug Development
Drug Development
Disease Research
Disease Research

Omni Bead Ruptor Elite homogenizer specifications video
Revvity Logo

©2026 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.